Mineralys Therapeutics
MLYS
#4511
Rank
A$3.21 B
Marketcap
A$39.04
Share price
2.12%
Change (1 day)
76.72%
Change (1 year)

Quarterly Reports (10-Q)

Latest form 10-Q quarterly reports for Mineralys Therapeutics CIK: 0001933414

Thumbnail Mineralys Therapeutics 10-Q Quarterly Report FY2025

10-Q Quarterly Report FY2025 Q3

Language: English

Quarterly Reports (10-Q)
Thumbnail Mineralys Therapeutics 10-Q Quarterly Report FY2025

10-Q Quarterly Report FY2025 Q2

Language: English

Quarterly Reports (10-Q)
Thumbnail Mineralys Therapeutics 10-Q Quarterly Report FY2025

10-Q Quarterly Report FY2025 Q1

Language: English

Quarterly Reports (10-Q)
Thumbnail Mineralys Therapeutics 10-Q Quarterly Report FY2024

10-Q Quarterly Report FY2024 Q3

Language: English

Quarterly Reports (10-Q)
Thumbnail Mineralys Therapeutics 10-Q Quarterly Report FY2024

10-Q Quarterly Report FY2024 Q2

Language: English

Quarterly Reports (10-Q)
Thumbnail Mineralys Therapeutics 10-Q Quarterly Report FY2024

10-Q Quarterly Report FY2024 Q1

Language: English

Quarterly Reports (10-Q)
Thumbnail Mineralys Therapeutics 10-Q Quarterly Report FY2023

10-Q Quarterly Report FY2023 Q3

Language: English

Quarterly Reports (10-Q)
Thumbnail Mineralys Therapeutics 10-Q Quarterly Report FY2023

10-Q Quarterly Report FY2023 Q2

Language: English

Quarterly Reports (10-Q)
Thumbnail Mineralys Therapeutics 10-Q Quarterly Report FY2023

10-Q Quarterly Report FY2023 Q1

Language: English

Quarterly Reports (10-Q)